Peer-reviewedCC BYACG case reports journal
Endoscopic Ultrasound-Guided Radiofrequency Ablation for an Adrenocorticotropic Hormone-Secreting Pancreatic Neuroendocrine Tumor on Antiplatelet Therapy.
- 1Department of Internal Medicine, University of Minnesota, Minneapolis, MN.
- 2Division of Gastroenterology, Hepatology and Nutrition, Department of Medicine, University of Minnesota, Minneapolis, MN.
Abstract
Endoscopic ultrasound (EUS)-guided radiofrequency ablation (RFA) has been used for thermal destruction of precancerous insulinomas and nonfunctioning pancreatic neuroendocrine tumors (pNETs) by coagulative necrosis. We report a case of a critically ill patient with an adrenocorticotropic hormone (ACTH)-secreting pNET treated with EUS-guided RFA (EUS-RFA) while on a P2Y12 antiplatelet after temporary stabilization on a titratable continuous etomidate infusion. This case demonstrates the novelty of EUS-RFA as a procedural treatment option for functional pNETs in critically ill, nonsurgical candidates on antiplatelet therapy.
Related
- Ultrasound-guided hydrodissection combined with radiofrequency for refractory occipital neuralgia: clinical outcomes, durability, and factors associated with repeat intervention
- The efficacy and safety of endoscopic resection for multiple rectal neuroendocrine tumors: a retrospective cohort study from a tertiary center
- Endoscopic ultrasound-guided left gastric vein embolization: a novel minimally invasive approach for gastroesophageal varices-1.
- A novel single-catheter access device for endoscopic ultrasound-guided hepaticogastrostomy.
- Endoscopic ultrasound-guided fine-needle biopsy of abdominal lymphadenopathy in Kimura's disease.
BibTeX
@article{langton2026endoscopic,
title = {{Endoscopic Ultrasound-Guided Radiofrequency Ablation for an Adrenocorticotropic Hormone-Secreting Pancreatic Neuroendocrine Tumor on Antiplatelet Therapy.}},
author = {Olivia Langton and Sai Sudha Valisekka and Rahul Karna and Guru Trikudanathan},
journal = {ACG case reports journal},
year = {2026},
month = oct,
doi = {10.14309/crj.0000000000002374},
url = {https://europepmc.org/article/MED/42953888},
note = {CC BY},
}
RIS
TY - JOUR
TI - Endoscopic Ultrasound-Guided Radiofrequency Ablation for an Adrenocorticotropic Hormone-Secreting Pancreatic Neuroendocrine Tumor on Antiplatelet Therapy.
AU - Olivia Langton
AU - Sai Sudha Valisekka
AU - Rahul Karna
AU - Guru Trikudanathan
PY - 2026
DA - 2026/10/28
JO - ACG case reports journal
DO - 10.14309/crj.0000000000002374
UR - https://europepmc.org/article/MED/42953888
AB - Endoscopic ultrasound (EUS)-guided radiofrequency ablation (RFA) has been used for thermal destruction of precancerous insulinomas and nonfunctioning pancreatic neuroendocrine tumors (pNETs) by coagulative necrosis. We report a case of a critically ill patient with an adrenocorticotropic hormone (ACTH)-secreting pNET treated with EUS-guided RFA (EUS-RFA) while on a P2Y12 antiplatelet after temporary stabilization on a titratable continuous etomidate infusion. This case demonstrates the novelty of EUS-RFA as a procedural treatment option for functional pNETs in critically ill, nonsurgical candidates on antiplatelet therapy.
SN - 2326-3253
ER -